March 17th, 2025 | 07:00 CET
Palantir, NetraMark, Alibaba – AI stocks set for an upward trend
For the first time in history, the German leading index, DAX, broke through the historic 23,000-point mark in the past trading week. There were also records to report for the precious metal gold, which jumped over the USD 3,000 per ounce mark. In comparison, US indices, like the Dow Jones or Nasdaq, are still in a correction cycle. However, signs of stabilization are emerging, particularly with the Nasdaq, which may present interesting entry opportunities after the massive losses in tech stocks.
time to read: 3 minutes
|
Author:
Stefan Feulner
ISIN:
PALANTIR TECHNOLOGIES INC | US69608A1088 , NETRAMARK HOLDINGS INC | CA64119M1059 , ALIBABA GROUP HLDG LTD | KYG017191142
Table of contents:
"[...] In Canada, there is $1.75 of debt for every dollar of disposable income - and that was true even before the pandemic. [...]" Karim Nanji, CEO, Marble Financial
Author
Stefan Feulner
The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.
Tag cloud
Shares cloud
Palantir – Fallen angel on the verge of a new upswing
The data specialist from Denver, Colorado, was the star of the tech sky in the past stock market year. Driven by the hype surrounding artificial intelligence, Palantir shares performed at over 660% from January 2024 to the all-time high of USD 125.41 in mid-February of the current stock market year. Since then, the share price has been undergoing a healthy correction, falling by around 40% to an interim low of USD 75.53. At this level, the 100-day EMA acts as support.
In addition, the gap that opened in February was closed in a textbook manner. Looking at the indicators, the consolidation may have already come to an end. The Relative Strength Index (RSI) already generated a buy signal last week, while the slower trend-following indicator MACD is also turning upward and is expected to jump into positive territory in the coming trading days.
The speech by CEO Alex Karp at AIPCon in Palo Alto also helped to stabilize Palantir's share price. Several partnerships were announced here, particularly in the field of defense technology. In addition to collaborations with Saildrone, a start-up that focuses on autonomous shipping, and Saronic Technologies, a joint venture was entered into with Epirus, which is involved in drone defense weapons.
Archer Aviation is also working to create the AI foundation for the future of next-generation aviation technologies. Alex Karp described the collaboration as follows: "By integrating Palantir's advanced AI capabilities with Archer's innovative approach to aircraft design and operations, we are laying the groundwork for a breakthrough in efficiency, safety, and sustainability."
NetraMark – The dawn of a new era
NetraMark's market capitalization is around CAD 116 million after the stock rallied around 900% since August of last year. Given the growth rates being called for in industry, the share price of CAD 1.55 seems to represent only an intermediate target. According to Mordorintelligence.com, revenues from artificial intelligence in the pharmaceutical industry are expected to increase sixfold to around USD 18 billion by the end of the decade compared to 2024.
NetraMark's vision is nothing less than to revolutionize clinical trials in the pharmaceutical industry through the use of modern data analysis. The Company recently reached another milestone with the launch of NetraAI 2.0, a next-generation platform designed to improve clinical trial analysis. NetraAI 2.0 offers advanced features to help clinical trial sponsors gain valuable insights, optimize inclusion and exclusion criteria, and thus create the conditions for successful registration trials.
By transforming clinical trial data into actionable insights, the platform improves decision-making and significantly reduces study timelines.
In addition to the outstanding announcements regarding business development in recent weeks, NetraMark was able to generate total proceeds of CAD 1,853,054 by exercising 4,805,279 warrants of the Company from December 12, 2024, to March 9, 2025, and further strengthen its balance sheet. The capital raised will be used to accelerate the commercialization and expansion of the Canadian company's AI solutions.
Lyndsay Malchuk discussed further details about NetraMark with NetraMark CEO George Achilleos in an in-depth interview.
Alibaba – Onwards and upwards
In contrast to Palantir, the chart formation for the Chinese e-commerce giant continues to point upwards. A break above the 2022 high at USD 145.3 would generate a new buy signal, giving potential for a follow-through to the 2020 high at USD 182.09.
Fundamentally, Alibaba continues to attract attention when it comes to AI models. With the version of its Quark app, the innovator is focusing on a 360-degree solution that combines chatbot functionality, in-depth analysis, and automated task management. It was reported that the previous AI models, known as QuarkLLM, will be expanded to include Qwen AI. This should lead to more efficient processes and deeper insights.
To strengthen its long-term position, Alibaba announced last month that it would invest USD 52.5 billion in the further expansion of its cloud and AI infrastructure. Recent benchmarks demonstrate the competitiveness of the Qwen AI model, which can compete with the leading solutions on the market.
Recently, Alibaba presented the QwQ-32B model, which, according to the Company, is comparable to leading models such as DeepSeek-R1. AI research is declared a strategic priority. Alibaba CEO Joe Tsai emphasized in an article for the South China Morning Post that the true value of technology can only be fully realized through its practical application.
Palantir's share price is stabilizing after a sharper correction. Alibaba is building on its leadership in the AI market. NetraMark was able to increase its balance sheet with a capital inflow of CAD 1,853,054 through the exercise of warrants.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.
In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.
The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.
